Assignee
MEDIVIR AB
SE91 patents
Top patents by PatentIndex Score
US9828408B2Nov 28, 2017
HCV polymerase inhibitors
MEDIVIR AB53 citations95
US9540411B2Jan 10, 2017
HCV polymerase inhibitors
MEDIVIR AB43 citations95
US9481703B2Nov 1, 2016
HCV polymerase inhibitors
MEDIVIR AB44 citations95
US6458772B1Oct 1, 2002
Prodrugs
MEDIVIR AB53 citations95
US7666856B2Feb 23, 2010
Antiviral nucleosides
MEDIVIR AB36 citations94
US5593993AJan 14, 1997
Method for inhibition of HIV related viruses
MEDIVIR AB62 citations93
US6337324B1Jan 8, 2002
Pharmaceutical combination
MEDIVIR AB43 citations90
US5714503AFeb 3, 1998
Compounds and methods for inhibition of HIV and related viruses
MEDIVIR AB27 citations90
US5446029AAug 29, 1995
Anti-retroviral activity of 2',3'-dideoxy-3'-fluoronucleosides
MEDIVIR AB42 citations90
US5576429ANov 19, 1996
5-substituted pyrimidine nucleosides and nucleotides
MEDIVIR AB51 citations89
US7671032B2Mar 2, 2010
HCV NS-3 serine protease inhibitors
MEDIVIR AB18 citations88
US7608590B2Oct 27, 2009
HCV NS-3 serine protease inhibitors
MEDIVIR AB23 citations88
US7601702B2Oct 13, 2009
Dutpase Inhibitors
MEDIVIR AB28 citations88
US5409906AApr 25, 1995
α nucleoside compounds and a method for treating HBV using said compounds
MEDIVIR AB21 citations88
US5215971AJun 1, 1993
Antiviral pharmaceutical composition comprising 5-substituted pyrimidine nucleosides
MEDIVIR AB40 citations88
US5849769ADec 15, 1998
N-arylalkyl-N-heteroarylurea and guandine compounds and methods of treating HIV infection
MEDIVIR AB36 citations87
USRE39264ESep 5, 2006
Pharmaceutical combination
MEDIVIR AB19 citations86
US5473063ADec 5, 1995
Synthesis of furanosyl compounds useful as intermediates in preparation of nucleoside analogues
MEDIVIR AB34 citations86
US10596220B2Mar 24, 2020
SMAC mimetic
MEDIVIR AB3 citations84
US9200006B2Dec 1, 2015
Protease inhibitors
MEDIVIR AB5 citations83
US7893067B2Feb 22, 2011
Cysteine protease inhibitors
MEDIVIR AB8 citations82
US10144750B2Dec 4, 2018
Dioxolane analogues of cytidine for the treatment of cancer
MEDIVIR AB6 citations81
US8735395B2May 27, 2014
Protease inhibitors
MEDIVIR AB5 citations81
US5869493AFeb 9, 1999
Acyclic nucleoside derivatives
MEDIVIR AB15 citations80
US5284837AFeb 8, 1994
Derivatives of purine, process for their preparation and a pharmaceutical preparation
MEDIVIR AB17 citations79
US7700552B2Apr 20, 2010
Macrocyclic inhibitors of hepatitis C virus
MEDIVIR AB18 citations77
US11351221B2Jun 7, 2022
SMAC mimetic
MEDIVIR AB1 citations73
US10723709B2Jul 28, 2020
Protease inhibitors
MEDIVIR AB1 citations72
US7825238B2Nov 2, 2010
Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosine
MEDIVIR AB5 citations72
US7071173B2Jul 4, 2006
Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosine
MEDIVIR AB5 citations72
US6974802B2Dec 13, 2005
Treatment of viral infections using prodrugs of 2′,3-dideoxy,3′-fluoroguanosine
MEDIVIR AB4 citations72
US6703394B2Mar 9, 2004
Acyclic nucleoside derivatives
MEDIVIR AB12 citations71
US6255312B1Jul 3, 2001
Acyclic nucleoside derivatives
MEDIVIR AB8 citations71
US5036071AJul 30, 1991
Derivatives of purine
MEDIVIR AB15 citations71
US11447511B2Sep 20, 2022
Dioxolane analogues of uridine for the treatment of cancer
MEDIVIR AB2 citations70
US10822360B2Nov 3, 2020
Dioxolane analogues of uridine for the treatment of cancer
MEDIVIR AB1 citations70
US10654877B2May 19, 2020
Dioxolane analogues of uridine for the treatment of cancer
MEDIVIR AB2 citations70
US10336780B2Jul 2, 2019
Dioxolane analogues of uridine for the treatment of cancer
MEDIVIR AB3 citations70
US5215970AJun 1, 1993
Nucleosides and nucleotide analogues, pharmaceutical composition and processes for the preparation of the compounds
MEDIVIR AB10 citations70
US7189849B2Mar 13, 2007
Synthesis of acyclic nucleoside derivatives
MEDIVIR AB6 citations69
US5656617AAug 12, 1997
Derivatives of purine, process for their preparation and a pharmaceutical preparation
MEDIVIR AB11 citations69
US5565461AOct 15, 1996
Derivatives of purine, process for their preparation and a pharmaceutical preparation
MEDIVIR AB12 citations69
US7825239B2Nov 2, 2010
Antiviral nucleosides
MEDIVIR AB6 citations68
US5747473AMay 5, 1998
L-nucleoside analogues and pharmaceutical compositions
MEDIVIR AB7 citations67
US5440040AAug 8, 1995
Pyrimidine intermediates
MEDIVIR AB13 citations67
US10456413B2Oct 29, 2019
Combination therapy with sorafenib or regorafenib and a phosphoramidate prodrug of troxacitabine
MEDIVIR AB2 citations66
US6486183B1Nov 26, 2002
Antivirals
MEDIVIR AB6 citations65
US12378209B2Aug 5, 2025
Protease inhibitors
MEDIVIR AB0 citations62
US11951147B2Apr 9, 2024
SMAC mimetic
MEDIVIR AB0 citations62
US11312693B2Apr 26, 2022
Protease inhibitors
MEDIVIR AB0 citations62
Showing the top 50 of 91 patents by PatentIndex Score.